Management and financials
CVR: 41898666
Secondary names: BioInnovation Institute Foundation (Fond), BII-Fonden, BII Foundation (Fond)
DKK 87,901,000
Revenue
Net result: DKK 191,715,000
No owners listed
CVR · view owners
Jens Bredal Nielsen
Board: Marianne Philip (chair) and 5 members
CVR · view management
Active
Founded 1 December 2020
CVR · view overview
129 employees
CVR · 2026
Name registered: BioInnovation Institute Fonden
CVR · 01/12/2020
View the full event history
BioInnovation Institute Fonden is a Danish company of the type Erhvervsdrivende fond based in København N, founded in 2020. The company is registered under the industry Trusters aktiviteter. The management consists of Jens Bredal Nielsen. The board consists of Marianne Philip (chair), Robert Glen Urban, James Walter Glasheen and Mads Krogsgaard Thomsen. The company has 129 employees (2026). In 2025, the company reported revenue of DKK 87,901,000 and a net result of DKK 191,715,000 compared with DKK 448,772,000 the year before. Equity in the 2025 report amounted to DKK 738,322,000.
Source: annual report 2025, Danish Business Authority
The financial health of BioInnovation Institute Fonden appears robust, marked by significant profitability and a strong equity position. In 2025, the company reported a revenue of 87.9 million DKK and a profit of 191.7 million DKK, reflecting a notable increase in revenue from 64.8 million DKK in 2024, despite a decrease in profit during the same period. The equity has remained substantial, totaling 738.3 million DKK in 2025, indicating a solid foundation for future growth. Overall, the company is on a strong upward trajectory, showcasing impressive margins and a growing presence within the trust activities sector.
AI-generated summary · Generated 25/03/2026
Fonden har til formål med almennyttigt sigte at eje og drive BioInnovation Institute og at fremme forskning, innovation og iværksætteri til gavn for almenheden, herunder ved at finansiere og støtte udvikling af opfindelser, opdagelser og selskaber inden for bioteknologi- og life science-sektoren, for derved at skabe et grundlag for vækst og jobskabelse inden for bioteknologi og life science. Fonden kan også yde støtte til andre almennyttige videnskabelige formål inden for bioteknologi og life science.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 87.9M | 191.7M | 882.2M | 738.3M | 126 | |
| 202401/01/2024 – 31/12/2024 | 64.8M | 448.8M | 944.3M | 807.7M | 105 | |
| 202301/01/2023 – 31/12/2023 | 68.3M | 349.8M | 739.3M | 617.3M | 78 | |
| 202201/01/2022 – 31/12/2022 | 20.7M | 293.3M | 519.6M | 437.7M | 48 | |
| 202101/01/2021 – 31/12/2021 | 1.4M | 349M | 371.3M | 325.4M | 31 |
Compared to 114 companies in Trusters aktiviteter
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of BioInnovation Institute Fonden is 41898666.
The management of BioInnovation Institute Fonden consists of Jens Bredal Nielsen.
The board of BioInnovation Institute Fonden consists of Marianne Philip, Robert Glen Urban and James Walter Glasheen, with Marianne Philip as chair.
In 2025, BioInnovation Institute Fonden reported revenue of DKK 87,901,000.
BioInnovation Institute Fonden had 129 employees in 2026 according to the Danish CVR register.
BioInnovation Institute Fonden was founded on 1 December 2020.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new website: www.bioinnovationinstitute.com (May 23, 2026).
Contact info changed: new website: www.bioinnovationinstitute.com (May 12, 2026).
BioInnovation Institute Fonden has published its annual report for 2025. Revenue came to DKK 87,901,000, and the net result was DKK 191,715,000.
As of March 18, 2026, James Walter Glasheen has joined the board of directors of BioInnovation Institute Fonden.
As of March 18, 2026, Hans Thalsgård Schambye has left the board of directors of BioInnovation Institute Fonden.
BioInnovation Institute Fonden has published its annual report for 2024. Revenue came to DKK 64,808,000, and the net result was DKK 448,772,000.
BioInnovation Institute Fonden has published its annual report for 2023. Revenue came to DKK 68,323,000, and the net result was DKK 349,750,000.
BioInnovation Institute Fonden has published its annual report for 2022. Revenue came to DKK 20,742,000, and the net result was DKK 293,322,000.
As of March 21, 2023, Marianne Philip has joined the board of directors of BioInnovation Institute Fonden.
As of March 21, 2023, Mads Krogsgaard Thomsen has joined the board of directors of BioInnovation Institute Fonden.
As of March 21, 2023, Sten Scheibye has left the board of directors of BioInnovation Institute Fonden.
As of March 21, 2023, Birgitte Nauntofte has left the board of directors of BioInnovation Institute Fonden.
As of March 21, 2023, Thomas Schafer has left the board of directors of BioInnovation Institute Fonden.
As of March 21, 2023, Bo Arthur Ahrén has left the board of directors of BioInnovation Institute Fonden.
As of March 20, 2023, Marianne Philip has left the board of directors of BioInnovation Institute Fonden.
BioInnovation Institute Fonden has published its annual report for 2021. Revenue came to DKK 1,389,000, and the net result was DKK 349,049,000.
As of March 21, 2021, Robert Glen Urban has joined the board of directors of BioInnovation Institute Fonden.
As of March 20, 2021, Robert Glen Urban has left the board of directors of BioInnovation Institute Fonden.
BioInnovation Institute Fonden has published its interim report for the period December 1, 2020 to December 31, 2020.
As of December 1, 2020, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of BioInnovation Institute Fonden.
As of December 1, 2020, Marianne Philip has joined the board of directors of BioInnovation Institute Fonden.
As of December 1, 2020, Hans Thalsgård Schambye has joined the board of directors of BioInnovation Institute Fonden.
As of December 1, 2020, Sten Scheibye has joined the board of directors of BioInnovation Institute Fonden.
As of December 1, 2020, Birgitte Nauntofte has joined the board of directors of BioInnovation Institute Fonden.
As of December 1, 2020, Martin Bonde has joined the board of directors of BioInnovation Institute Fonden.
As of December 1, 2020, Thomas Schafer has joined the board of directors of BioInnovation Institute Fonden.
As of December 1, 2020, Regina Hodits has joined the board of directors of BioInnovation Institute Fonden.
As of December 1, 2020, Bo Arthur Ahrén has joined the board of directors of BioInnovation Institute Fonden.
As of December 1, 2020, Robert Glen Urban has joined the board of directors of BioInnovation Institute Fonden.
As of December 1, 2020, Jens Bredal Nielsen is registered as adm. dir. of BioInnovation Institute Fonden.
BioInnovation Institute Fonden was founded on December 1, 2020.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 11679935
CVR 46674804
CVR 33044380
CVR 34671834
CVR 18784106
